Cargando…
2020년 개정 진료 치침에 따른 과민성폐렴의 진단
Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514409/ https://www.ncbi.nlm.nih.gov/pubmed/36238061 http://dx.doi.org/10.3348/jksr.2021.0075 |
_version_ | 1784798267963342848 |
---|---|
collection | PubMed |
description | Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited to antigen avoidance. The differential diagnosis of HP from other ILDs is the beginning of treatment as well as diagnosis. However, the presence of several overlapping clinical and radiologic features makes differentiating HP from other ILDs particularly challenging. In 2020, a multidisciplinary committee of experts from the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax suggested a new clinical practice guideline classifying HP into nonfibrotic and fibrotic phenotypes on the basis of chest high-resolution CT (HRCT) findings. Therefore, we introduced a new diagnostic algorithm based on chest HRCT in the clinical practice guideline for the diagnosis of HP. |
format | Online Article Text |
id | pubmed-9514409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society of Radiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-95144092022-10-12 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 Taehan Yongsang Uihakhoe Chi Updates in Chest Radiology Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) characterized by an inhaled inciting antigen that leads to the inflammation of the lung parenchyma and small airway with immunologic reactions. Over the last decades, the most effective therapeutic option for HP has been limited to antigen avoidance. The differential diagnosis of HP from other ILDs is the beginning of treatment as well as diagnosis. However, the presence of several overlapping clinical and radiologic features makes differentiating HP from other ILDs particularly challenging. In 2020, a multidisciplinary committee of experts from the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax suggested a new clinical practice guideline classifying HP into nonfibrotic and fibrotic phenotypes on the basis of chest high-resolution CT (HRCT) findings. Therefore, we introduced a new diagnostic algorithm based on chest HRCT in the clinical practice guideline for the diagnosis of HP. The Korean Society of Radiology 2021-07 2021-07-26 /pmc/articles/PMC9514409/ /pubmed/36238061 http://dx.doi.org/10.3348/jksr.2021.0075 Text en Copyrights © 2021 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Updates in Chest Radiology 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title_full | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title_fullStr | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title_full_unstemmed | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title_short | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
title_sort | 2020년 개정 진료 치침에 따른 과민성폐렴의 진단 |
topic | Updates in Chest Radiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514409/ https://www.ncbi.nlm.nih.gov/pubmed/36238061 http://dx.doi.org/10.3348/jksr.2021.0075 |
work_keys_str_mv | AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan AT 2020nyeongaejeongjinlyochichimettaleungwaminseongpyelyeomuijindan |